Concepedia

Publication | Open Access

The Ultra-Potent and Selective TLR8 Agonist VTX-294 Activates Human Newborn and Adult Leukocytes

DOIFull Paper Access

65

Citations

45

References

2013

Year

David J. Dowling, Zhen Tan, Zofia Prokopowicz, Christine D. Palmer, Maura-Ann H. Matthews, Gregory N. Dietsch, Robert M. Hershberg, Ofer Levy
PLoS ONE

Abstract

VTX-294 is a novel ultra-potent TLR8 agonist that activates newborn and adult leukocytes and is a candidate vaccine adjuvant in both early life and adulthood.

References

YearCitations

Page 1